NPR News·4 min read·medium
What's behind the push to make peptide therapies more readily available
W
Will Stone
✦AI Summary
Medical experts are raising concerns about the lack of clinical evidence for popular peptide therapies, which are currently being promoted in wellness circles. The FDA is set to review whether to allow compounding pharmacies to manufacture these substances, potentially ending their current grey-market status.
Every day, Dr. Alexander Weber finds himself fielding another round of questions about peptides — and whether the trendy therapies can help his patients recover from sports injuries or surgery.
healthsciencepolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in